Abankwa D, Küry P, Müller HW. Dynamic changes in gene expression profiles following axotomy of projection fibers in the mammalian CNS. Molecular Cellular Neuroscience2002; 21: 421-435.

Arendt G, Giesen HJv, Husstedt IW, Maschke M, Sporer B, Weber Th. HIV-1-assoziierte Erkrankungen. In: Diener HC Leitlinien DGN Georg Thieme Verlag, Stuttgart, 2002; 94-99.

Arendt G, Giesen HJv. Antiretroviral Therapy Regimens for Neuro-AIDS. Current Drug Targets - Infectious Disorders (CDT - ID) 2002; 2: 187-192.

Arendt G, Giesen HJv. HIV-dementia: evidence of a subcortical process from studies of fine finger movements. Journal of Neurovirology 2002; 8: 27-32.

Baumhackl U, Eibl G, Ganzinger U, Hartung HP, Mamoli B, Pfeiffer KP, Fazekas F, Vass K. Prevalence of multiple sclerosis in Austria. Results of a nationwide survey. Neuroepidemiology 2002; 21: 226-234.

Bernal F, Hartung HP,Kieseier BC. Multiple sclerosis: many markers and many more questions. Clinical Laboratory International2002; 26: 8-10.

Binkofski F, Fink GR, Geyer S, Buccino G, Gruber O, Shah NJ, Taylor JG, Seitz RJ, Zilles K, Freund HJ. Neural activity in human primary motor cortex areas 4a and 4p is modulated differentially by attention to action. Journal of Neurophysiology 2002; 88: 514-519.

Clanet M, Radue EW, Kappos L, Hartung HP, Hohlfeld R, Sandberg-Wollheim M, Kooijmans-Coutinho MF, Tsao EC, Sandrock AW. A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS. Neurology 2002; 59: 1507-1517.

Dawkins JL, Brahmbhatt S, Auer-Grumbach M, Wagner K, Hartung HP, Verhoeven K, Timmerman V, De Jonghe P, Kennerson M, LeGuern E, Nicholson GA. Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy. Neuromuscular Disorders 2002; 12: 656-658.

De Jonghe P, Auer-Grumbach M, Irobi J, Wagner K, Plecko B, Kennerson M, Zhu D, De Vriendt E, Van Gerwen V, Nicholson G, Hartung HP, Timmerman V. Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain2002; 125: 1320-1325.

De Souza Silva MA, Jezek K, Weth K, Müller HW, Huston JP, Brandao ML, Hasenöhrl RU. Facilitation of learning and modulation of frontal cortex acetylcholine by ventral pallidal injection of heparin glucosaminoglycan. Neuroscience 2002; 113: 529-535.

Deutsche Neuro-AIDS Arbeitsgemeinschaft (DNAA). Aktuelle Diagnostik und Therapie opportunistischer Hirnerkrankungen bei AIDS. Deutsche Medizinische Wochenschrift2002; 27: 1479-1485.

Dihne M, Grommes C, Lutzenburg M, Witte OW, Block F. Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke 2002; 33: 3006-3011.

Dodel R, Hampel H, Depboylu C, Lin S, Gao F, Schock S, Jäckel S, Wie X, Buerger K, Höft C, Hemmer B, Möller HJ, Farlow M, Oertel WH, Sommer N, Du Y. Human antibodies against amyloid b-peptide. A potential treatment for Alzheimer disease. Annals of Neurology 2002; 52: 253-256.

Ebert D, Hefter H, Binkofski F, Freund HJ. Coordination between breathing and mental grouping of pianistic finger movements. Perception Motor Skills 2002; 95: 339-353.

Erhardt A, Hoffmann A, Hefter H, Haussinger D. HFE gene mutations and iron metabolism in Wilson's disease. Liver 2002; 22: 474-478.

Eggers C and the Neuro-AIDS study group. HIV-1-associated encephalopathy and myelopathy. Journal of Neurology 2002; 249: 1132-1136.

Fiehler J, Fiebach JB, Gass A, Hoehn M, Kuchiinski T, Neumann-Haefelin T, Schellinger PD, Siebler M, Villringer A, Röther J. Diffusion-weighted imaging in acute stroke-a tool of uncertain value? Cerebrovascular Disorders 2002; 14: 187-196.

Ghalie RG, Edan G, Laurent M, Mauch E, Eisenman S, Hartung HP, Gonsette RE, Butine MD, Goodkin DE. Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS. Neurology 2002; 59: 909-913.

Ghalie RG, Mauch E, Edan G, Hartung HP, Gonsette RE, Eisenmann S, Le Page E, Butine MD, De Goodkin DE. A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis. Multiple Sclerosis 2002; 8: 441-445.

Giesen HJv, Arendt G. Drug treatment for HIV-1-associated dementia. Current Opinion in Investigational Drugs 2002; 3: 1643-1646.

Giesen HJv, Arendt G, Berger J, Levy R. Proceedings of the 19th Neurosciences of HIV Infection Meeting: Emergingissues. Proceedings Journal of Neurovirology 8: Rosenkranz und die DNAA. Aktuelle Diagnostik und Therapie opportunistischer Hirnerkrankungen bei AIDS. Deutsche Medizinische Wochenschrift 2002;127: 1479-1485.

Giesen HJv, Köller H, Theisen A, Arendt G. Therapeutic effects of nonnucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected patients. Journal of AIDS Research 2002; 29: 363-367.

Giesen HJv, Koeller H, Arendt G. Anmerkungen zur Therapie der HIV-1-Infektion aus neurologischer Sicht. Münchener Medizinische Wochenzeitschrift-Fortschritte der Medizin 2002; 144: 291-295.

Giesen HJv, Köller H, Hefter H, Arendt G. Central and peripheral nervous system functions are independently disturbed in HIV-1 infected patients. Journal of Neurology 2002; 249: 754-758.

Giesen HJv, Kaiser R, Köller H, Wetzel K, Arendt G. Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 2002; 59: 474-475.

Giesen HJv, Köller H, Arendt G. Behandlung der HIV-1 Infektion aus neurologischer Sicht. Münchener Medizinische Wochenschrift, 2002; 144: 46-50.

GrossJ, Timmermann L, Kujala J, DirksM, Schmitz F, Salmelin R, Schnitzler A. The neural basis of intermittent motor control in man. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 2299-2302.

Hartung HP, Gonsette R, Konig N, Kwiecinski H, Guseo A, Morrissey SP, Krapf H, Zwingers T. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet2002; 360: 2018-2025.

Hartung HP, Kieseier BC, Stangel M, Archelos JJ. High-dose IVIG therapy for immune neuropathies: efficacy and mechanisms of action. In: Kiehl, Naß, Volk (eds.) Immunomodulation with immunoglobulins for autoimmune diseases and infectionsGeorg-Thieme-Verlag, Stuttgart, 2002; 48-55.

Hartung HP, Toyka KV, Kieseier BC. Immune mechanisms in neurological disease. In: AK Asbury, GM McKhann, WI Mc Donald, PJ Goadsby, J McArthur (eds.) Diseases of the nervous system: clinical neuroscience and therapeutic principles2ndedition,Cambridge Universitiy Press, Cambridge, 2002; 1501-1526.

Hartung HP, Willison HJ, Kieseier BC. Acute immunoinflammatory neuropathy: Update on Guillain-Barré syndrome. Current Opinion in Neurology 2002; 15: 571-577.

Hasse B, Bosse F, Müller HW. Peripheral myelin proteins are associated with glycosphingolipid/cholesterol-enriched membranes (GEMs). Journal of Neuroscience Research 2002; 69: 227-232.

Hemmer B, Archelos JJ, Hartung HP. New Concepts in the immunopathogenesis of multiple sclerosis. Nature Reviews Neuroscience 2002; 3: 291-391.

Hemmer B, Cepok S, Nessler S, Sommer N. Update on immunology of MS - Changing immuno-pathogenetic paradigms. Current Opinion in Neurology 2002; 15: 227-231.

Hemmer B, Epplen JT. Multiple Sklerose, Neurogenetik. In: Rieß O, Schöls L (eds.) Molekulargenetische Diagnostik neurologischer und psychiatrischer Erkrankungen. Kohlhammer 2002; 2. Auflage, 298-311.

Hemmer B. Pathogenese der Multiplen Sklerose. Aktuelle Neurologie 2002; Suppl. 477-479.

Jacobsen M, CepokS, GaberR, ZieglerA, OmerB, HolzbachR, SchockS, Oertel WH, Sommer N, Hemmer B. CD8+ T cell expansion in the cerebrospinal fluid from MS patients. Brain 2002; 125: 538-550.

Jacobsen M, Hoffmann S, Cepok S, Ziegler A, Sommer N, Hemmer B. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule. Immunogenetics 2002; 54: 158-163.

Jander S, Schroeter M, Stoll G. Interleukin-18 expression after focal ischemia of the rat brain: association with the late stage inflammatory response. Journal of Cerebral Blood Flow and Metababolism 2002; 22: 62-70.

Jander S, Stoll G. Increased serum levels of the interferon-g-inducing cytokine interleukin-18 in myasthenia gravis. Neurology 2002; 59:287-289.

Jander S, Bussini S, Neuen-Jakob E, Bosse F, Menge T, Müller HW, Stoll G. Osteopontin: A novel axon-regulated Schwann cell gene. Journal of Neuroscience Research2002; 67, 156-166.

Joost P, Methner A. Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biology 2002; 3: research 0063.1-0063.16.

Junghans U, Seitz RJ, Ritzl A, Wittsack HJ, Fink GR, Freund HJ, Siebler M. Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban. Neurology2002; 58: 474-476.

Junghans U, Seitz R, Wittsack HJ, Ritzl A, Fink G, Siebler M.Effect of Tirofiban in acute stroke. Neurology 2002; 58: 476-478.

Junghans U, Franken S, Pommer A, Müller HW, Viebahn C, Kappler J. A monoclonal antibody against a neuron-specific 65 kDa protein with laminar expression in the developing cerebral cortex. Histochemistry Cell Biology 2002; 117: 317-325.

Kessler K, Schnitzler A, Classen J, Benecke. Reduced inhibition within primary motor cortex in patients with poststroke focal motor seizures. Neurology 2002; 49: 1028-1033.

Kieseier BC, Dalakas MC, Hartung HP. Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 2002; 59: 7-12.

Kieseier BC, Hartung HP. Chemokines in the inflamed peripheral nervous system. In: Ransohoff R (ed.)Universes in delicate balance: chemokines and the nervous systemElsevier Sciene, Amsterdam, 2002; 375-380.

Kieseier BC, Hartung HP. Guillain-Barré Syndrome. Advances in Clinical Neurosciences2002; 12: 317-341.

Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies - a central role for IP-10. Brain2002; 125: 823-834.

Kircheis G, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low grade hepatic encephalopathy. Hepatology 2002; 35: 357-366.

Klapka N, Hermanns S, Müller HW. Interactions between glia and extracellular matrix and their role for axonal Growth. In: Aldskogius H, Fraher J (eds.) Glial Interfaces in the Nervous System - Role in Repair and Plasticity. IOS Press Amsterdam, 2002; 139-151.

Koeller H, Giesen HJv, Schaal H, Arendt G. Glutamate may be one of several factors that induce calcium dysregulation in cultured astrocytes in HIV dementia. AIDS 2002; 16: 1692-1693.

Köller H, Schaal H, Rosenbaum C, Czardybon M, Giesen vHJ, Müller HW, Arendt G. Functional CXCR4 receptor development parallels sensitivity to HIV-1 gp120 in cultured rat astroglial cells but not in cultured rat cortical neurons. Journal of Neurovirology 2002; 8: 411-419.

Küry P, Greiner-Petter R, Cornely C, Jürgens T, Müller HW. Mash 2 is expressed in the adult sciatic nerve and regulates the expression of Krox24, Mob-1, CXCR4 and p57kip2 in Schwann cells. Journal of Neuroscience 2002; 22: 7586-7595.

Leussink VI, Zettl UK, Jander S, Pepinsky RB, Lobb RR, Stoll G, Toyka KV, Gold R. Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T-cell apoptosis in sciatic nerve. Acta Neuropathologica 2002; 103:131-136.

Leypoldt F, Flajoleta M, Methner A. Synapsin I, II and especially Synapsin III are upregulated by retinoic acid-induced neuronal differentiation of human NT2 cells. Neuroscience Letters2002; 324: 37-40.

Menge T, Rzepka R, Melchers I. Monoclonal autoantibodies from patients with autoimmune diseases: specificity, affinity and crossreactivity of MAbs binding to cytoskeletal and nucleolar epitopes, cartilage antigens and mycobacterial heat-shock protein 60. Immunobiology 2002; 205: 1-16.

Müller HW. Innovativer Therapieansatz zur Regeneration von Nervenbahnen nach Hirn- und Rückenmarkverletzungen. In: Kaiser G, Süssmuth H (eds.) Jahrbuch der Heinrich-Heine-Universität Düsseldorf 2001. Heinrich-Heine-Universität Düsseldorf, 2002; 82-92.

Nessler S, Dodel R, Bittner A, Reuss S, Du Y, Hemmer B, Sommer N. Effect of minocycline in experimental autoimmune encephalomyelitis. Annals of Neurology 2002; 52: 689-690.

Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP, Archelos JJ. Statins as immunomodulators: comparison with interferon-b1b in MS. Neurology200259: 990-997.

Ommer A, Dziewanowski M, Pillny M, Huber R, Siebler M, Sandmann W. Long-term results after carotid reconstruction in patients with completed stroke caused by cerebrovascular occlusive disease. Deutsche Medizinische Wochenschrift 2002; 22; 127: 370-375.

Ploner M, Gross J, Timmermann L, Schnitzler A. Cortical representation of first and second pain sensation in humans. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 12444-12448.

Ploner M, Noetges P, Holthusen H, Schnitzler A. Cortical representation of venous nociception. Journal of Neurophysiology 2002; 88: 300-305.

Pollok B, MollM, Schmitz F, Müller K, Schnitzler A. Rapid Mapping of Finger Representations in Human Primary Somatosensory Cortex Applying Neuromagnetic Steady-State-Responses. Neuroreport 2002; 13: 235-238.

Quasthoff S, HartungHP. Chemotherapy-induced peripheral neuropathy. Journal of Neurology 2002; 249: 9-17.

Reichmann G, Schroeter M, Jander S, Fischer HG. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. Journal ofNeuroimmunology2002; 129: 125-132.

Rieckmann P, Toyka KV; Multiple Sklerose-Therapie-Konsensus-Gruppe [Hartung HP]. Immunmodulatorische Stufentherapie der Multiplen Sklerose. Neue Aspekte und praktische Umsetzung, März 2002. Nervenarzt 2002; 73: 556-563.

Rosenbaum T, Richter-Werkle R, Köller H, Lenard HG. Psychogenic contractures: the magic side of medicine. Neuropediatrics 2002; 33: 166-167.

Röther J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, Fiehler J, Jansen O, Kucinski T, Schoder V, Szabo K, Junge-Hülsing GJ, Hennerici M, Zeumer H, Sartor K, Weiller C, Hacke W. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 2002; 33: 2438-2445.

Scherer A, Aulich A, Siebler M. Virtual artrial endoscopy as a diagnostic aid in a patient with basilar artery fenestration and thrombembolic pontine infarct. American Journal of Neuroradiology 2002; 23: 1237-1239.

Schormann T, Kraemer M. Voxel-Guided Morphometry (VGM) and Application to Stroke. IEEE Transactions on Medical Imaging 2002; 22: 62-74.

Schroeter M, Jander S, Stoll G. Noninvasive induction of focal cerebral ischemia in mice by photothrombosis of cortical microvessels: Characterization of inflammatory responses. Journal of Neuroscience Methods 2002; 117: 43-49.

Schroeter M, Stoll G, Jander S. Targeting of astroglia and microglia reactions after focal cerebral ischemia.In:Krieglstein J, Klumpp S (eds.) Pharmacology of cerebral ischemia.Medpharm Scientific Publishers, Stuttgart, 2002; 97-104.

Schulze KMM, Hanemann CO, Müller HW, Hanenberg H. Transduction of wildtype merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis. Human Molecular Genetics 2002; 11: 69-76.

Seifert T, Kieseier BC, Ropele S, Strasser-Fuchs S, Quehenberger F, Fazekas F, Hartung HP. TACE mRNA expression in peripheral mononuclear cells precedes new lesions on MRI in multiple sclerosis. Multiple Sclerosis 2002; 8: 447-451.

Seitz RJ. Hemispheric dissociation of visual-pattern processing and visual rotation. Behavioural Brain Research 2002; 136: 533-544.

Siebler M, Seitz RJ, Junghans U. Tirofiban, a gpIIb/IIIa antagonist in acute ischemic stroke. Stroke 2002; 33: 382.

Siebler M, Seitz RJ, Hartung HP. Pro, Kontra, Re zur Mikroemboliedetektion. Nervenarzt2002; 73: 125-132.

Stangel M, Hartung HP. Despair of repair. Journal of Neurology, Neurosurgery and Psychiatry 2002; 72: 1-4.

Stangel M, Hartung HP. Remyelinating strategies for the treatment of multiple sclerosis. Progress Neurobiology 2002; 68: 361-76.

Stephan KM, Thaut MH, Wunderlich G, Schicks W, Tian B, Tellmann L, Schmitz T, Herzog H, McIntosh GC, Seitz RJ, Hömberg V. Conscious and subconscious sensorimotor synchronization-prefrontal cortex and the influence of awareness. Neuroimage 2002; 15: 345-352.

Stoeckel MC, Kleinschmidt A, Ebner A, Witte OW, Seitz RJ. Reorganization of motor representation in a patient with epilepsia partialis continua as shown by [O15]-labeled butanol positron emission tomography and functional magnetic resonance imaging. Journal of Neuroimaging 2002; 12: 276-281.

Stoll G, Jander S, Myers RR. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller´s observations to neuroinflammation. Journal of the Peripheral Nervous System 2002; 7: 13-27.

Stoll G, Jander S, Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Advances in Experimental Medicine and Biology 2002; 513: 87-113.

Stoll G, Jander S, Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. In: Alzheimer C (ed.) Molecular and Cellular Biology of Neuroprotection in the CNS.Landis Publ. 2002.

Stoll G, Jander S, Schroeter M. Microglia and macrophage responses in cerebral ischemia. In: Streit WJ (ed.) Microglia in the Regenerating and Degenerating CNS. Springer, New York, 2002; 125-151.

Stoll G, Jander S, Schroeter M. Microglia. In: Encyclopedia of the Human Brain. Vol. 3, Elsevier Science, 2002; 29-41.

Suchan B, Yaguez L, Wunderlich G, Canavan AG, Herzog H, Tellmann L, Hömberg V, Seitz RJ. Neural correlates of visuospatial imagery. Behavioural Brain Research 2002; 131: 163-168.

Thaut MH, Kenyon GP, Hurt CP, McIntosh GC, Hömberg V. Kinematic optimization of spatiotemporal patterns in paretic arm training with stroke patients. Neuropsychologia 2002; 40: 1073-1081.

Timmermann L, Gross J, Kircheis G, Häussinger D, Schnitzler A. Cortical Origin of Mini-Asterixis in Hepatic Encephalopathy. Neurology 2002; 58: 295-298.

Vogel F, Hemmer B. Innovative Strategien immunmodulatorischer Therapie bei multipler Sklerose. Nervenheilkunde 2002; 21: 508-511.

Warskulat U, Görg B, Bidmon HJ, Müller HW, Schliess F, Häussinger D. Ammonia-induced heme oxygenase-1 expression in cultured rat astrocytes and rat brain in vivo. Glia2002; 40: 324-336.

Willison H, Stoll G, Toyka KV, Berger T, Hartung HP. Autoimmunity and inflammation in the peripheral nervous system. Trends in Neurosciences 2002; 25: 127-129.

Wittsack HJ, Ritzl A, Fink GR, Wenserski F, Siebler M, Seitz RJ, Mödder U, Freund HJ. Magnetic resonance imaging in acute stroke: DWI and PI parameters predicting infarct outcome. Radiology 2002; 222: 397-403.

Ziemssen T, Kümpfel T, Klinkert WEF, Neuhaus O, Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain 2002; 125: 2381-2391.

Ziemssen T, Neuhaus O, Farina F, Hartung HP, Hohlfeld R. Behandlung der Multiplen Sklerose mit Glatiramer-Azetat: Aktuelles zu Wirkungsmechanismen, Pharmakokinetik, Nebenwirkungsprofil und Studiensituation. Nervenarzt 2002; 73: 321-331.

MediathekInformation und Wissen
LageplanSo finden Sie uns